Harvard University Associate Professor, Dr. Ovidiu Andronesi MD, PhD, will lead the study as the principal investigator. A direct comparison of AL001 to a commercially available lithium carbonate product will be conducted. The study aims to compare lithium levels in the human brain and its structures to identify a potentially optimal dose of AL001 that is both safe and effective…